Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Sandoz Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (682)
Cancellation by sponsor (321)
Prescription medicine registration (54)
Section 14, TGO91 consent (17)
Cancellation or suspension (8)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)

Date

2024 (82)
2023 (78)
2022 (67)
2021 (121)
2020 (153)
2019 (53)
2018 (60)
2017 (50)
2016 (4)
2015 (39)
2014 (20)
2013 (24)
2012 (13)
2011 (51)
2010 (47)
2009 (37)
2008 (27)
2007 (21)
2006 (21)
2005 (54)
2004 (12)
2003 (10)
2002 (10)
2001 (6)
2000 (5)
1999 (5)
1998 (9)
1997 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

1087 result(s) found, displaying 341 to 350

IRBESARTAN SZ irbesartan 75 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 November 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
IRBESARTAN SZ irbesartan 300 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 November 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
PARACETAMOL SANDOZ paracetamol 500mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 November 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
MENDELEEV IBUPROFEN 200 mg capsule shaped film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 November 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
FOSINOPRIL / HCT SANDOZ 20/12.5 fosinopril sodium20mg and hydrochlorothiazide 12.5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

3 November 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
FOSINOPRIL / HCT SANDOZ 10/12.5 fosinopril sodium10mg and hydrochlorothiazide 12.5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

3 November 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
FOSINOPRIL SANDOZ fosinopril sodium 20mg tablet bottle Cancelled under Section 30(1)(c) of the Act

3 November 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
FOSINOPRIL SANDOZ fosinopril sodium 10mg tablet bottle Cancelled under Section 30(1)(c) of the Act

3 November 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
SANDOZ NATURAL LAXATIVE WITH SOFTENER sennosides (as sennoside B) and docusate sodium film coated tablet bottle Cancelled under Section 30(1)(c) of the Act

3 November 2021

Cancellation by sponsor

Requested by Sandoz Pty Ltd
FULVESTRANT SANDOZ fulvestrant 250 mg/5 mL solution for injection in pre-filled syringe (323030)

26 May 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FULVESTRANT SANDOZ fulvestrant 250 mg/5 mL solution for injection in pre-filled syringe.

Pages

First page
Previous page
…
Page 31
Page 32
Page 33
Page 34
Current page 35
Page 36
Page 37
Page 38
Page 39
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.